(UPDATED) TAVI benefits were attenuated and mortality trended higher in PARTNER 3 at 5 years

(UPDATED) The trial had to switch out its hard primary endpoints for a win-ratio

(UPDATED) In patients not taking antianginal meds, PCI clearly alleviated some—but not all—symptoms

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

(UPDATED) The latest study to undermine the role of these long-standing agents suggests their